Replies to post #10537 on Biotech Values

[io_io]

"mild alzheimer's in most cases isn't detected

there is not a good early alzheimer's test."



that was exactly my point...... i think MYGN has nothing from this trial; or at least the opportunities out there based on real trail results are far more obvious than theirs.

some day I am going to buy back into Elan - their program is now undisputedly in the lead, and they have a real shot at the disease.